IDM Pharma Provides Update On Mifamurtide (L-MTP-PE) Regulatory Status Following - Congoo

|

|

News

Media & Advertising

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following

Have an interest in this Story?
Sign Up for Real-Time email updates

Healthcare Sales & Marketing Network | July 07, 2008

Company continues to anticipate CHMP opinion in the third quarter; L-MTP-PE on track for final European Commission decision in the fourth quarterIRVINE, Calif., July 1 (HSMN NewsFeed) -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that the CHMP, following their June 2008 meeting, has requested ...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Usain Bolt earns sprint double - Yahoo! Canada

Storm Fay drenches space shuttle port in Florida - Boston Globe

Pilot had reported fault in Madrid crash plane - Telegraph

Russia to Cut All Military Ties with NATO - Time

Suicide bombers attack Pakistan arms factory - CNN

Featured Members

Martin P. Lee
Mr
Knowledge Management

Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2008 Congoo.com. All Rights Reserved.